| Demonstrating stratification in a European American population CD Campbell, EL Ogburn, KL Lunetta, HN Lyon, ML Freedman, LC Groop, ... Nature genetics 37 (8), 868-872, 2005 | 545 | 2005 |
| Human copy number variation and complex genetic disease S Girirajan, CD Campbell, EE Eichler Annual review of genetics 45 (1), 203-226, 2011 | 436 | 2011 |
| Profiling critical cancer gene mutations in clinical tumor samples LE MacConaill, CD Campbell, SM Kehoe, AJ Bass, C Hatton, L Niu, ... PloS one 4 (11), e7887, 2009 | 369 | 2009 |
| Refinement and discovery of new hotspots of copy-number variation associated with autism spectrum disorder S Girirajan, MY Dennis, C Baker, M Malig, BP Coe, CD Campbell, K Mark, ... The American Journal of Human Genetics 92 (2), 221-237, 2013 | 345 | 2013 |
| Properties and rates of germline mutations in humans CD Campbell, EE Eichler Trends in Genetics 29 (10), 575-584, 2013 | 293 | 2013 |
| Association of MTOR mutations with developmental brain disorders, including megalencephaly, focal cortical dysplasia, and pigmentary mosaicism GM Mirzaa, CD Campbell, N Solovieff, CP Goold, LA Jansen, S Menon, ... JAMA neurology 73 (7), 836-845, 2016 | 266 | 2016 |
| Estimating the human mutation rate using autozygosity in a founder population CD Campbell, JX Chong, M Malig, A Ko, BL Dumont, L Han, L Vives, ... Nature genetics 44 (11), 1277-1281, 2012 | 250 | 2012 |
| TET2-driven clonal hematopoiesis and response to canakinumab: an exploratory analysis of the CANTOS randomized clinical trial EC Svensson, A Madar, CD Campbell, Y He, M Sultan, ML Healey, H Xu, ... JAMA cardiology 7 (5), 521-528, 2022 | 160 | 2022 |
| Structural diversity and African origin of the 17q21. 31 inversion polymorphism KM Steinberg, F Antonacci, PH Sudmant, JM Kidd, CD Campbell, L Vives, ... Nature genetics 44 (8), 872-880, 2012 | 156 | 2012 |
| Adjuvant dabrafenib plus trametinib versus placebo in patients with resected, BRAFV600-mutant, stage III melanoma (COMBI-AD): exploratory biomarker analyses from a randomised … R Dummer, JC Brase, J Garrett, CD Campbell, E Gasal, M Squires, ... The lancet oncology 21 (3), 358-372, 2020 | 135 | 2020 |
| Tracking the evolution of resistance to ALK tyrosine kinase inhibitors through longitudinal analysis of circulating tumor DNA I Dagogo-Jack, AR Brannon, LA Ferris, CD Campbell, JJ Lin, KR Schultz, ... JCO precision oncology 2, 1-14, 2018 | 131 | 2018 |
| PureCN: copy number calling and SNV classification using targeted short read sequencing M Riester, AP Singh, AR Brannon, K Yu, CD Campbell, DY Chiang, ... Source code for biology and medicine 11, 1-13, 2016 | 130 | 2016 |
| A large and complex structural polymorphism at 16p12. 1 underlies microdeletion disease risk F Antonacci, JM Kidd, T Marques-Bonet, B Teague, M Ventura, S Girirajan, ... Nature genetics 42 (9), 745-750, 2010 | 128 | 2010 |
| Population-genetic properties of differentiated human copy-number polymorphisms CD Campbell, N Sampas, A Tsalenko, PH Sudmant, JM Kidd, M Malig, ... The American Journal of Human Genetics 88 (3), 317-332, 2011 | 120 | 2011 |
| Combined PD-1, BRAF and MEK inhibition in advanced BRAF-mutant melanoma: safety run-in and biomarker cohorts of COMBI-i R Dummer, C Lebbé, V Atkinson, M Mandalà, PD Nathan, A Arance, ... Nature medicine 26 (10), 1557-1563, 2020 | 93 | 2020 |
| TET2-driven clonal hematopoiesis predicts enhanced response to canakinumab in the CANTOS trial: an exploratory analysis EC Svensson, A Madar, CD Campbell, Y He, M Sultan, ML Healey, ... Circulation 138 (Suppl_1), A15111-A15111, 2018 | 83 | 2018 |
| Independent mutational events are rare in the ATM gene: haplotype prescreening enhances mutation detection rate M Mitui, C Campbell, G Coutinho, X Sun, CH Lai, Y Thorstenson, ... Human mutation 22 (1), 43-50, 2003 | 74 | 2003 |
| Association studies of BMI and type 2 diabetes in the neuropeptide Y pathway: a possible role for NPY2R as a candidate gene for type 2 diabetes in men CD Campbell, HN Lyon, J Nemesh, JA Drake, T Tuomi, D Gaudet, X Zhu, ... Diabetes 56 (5), 1460-1467, 2007 | 64 | 2007 |
| Genome-wide association study and admixture mapping reveal new loci associated with total IgE levels in Latinos M Pino-Yanes, CR Gignoux, JM Galanter, AM Levin, CD Campbell, C Eng, ... Journal of Allergy and Clinical Immunology 135 (6), 1502-1510, 2015 | 63 | 2015 |
| Combined PD-1, BRAF and MEK inhibition in BRAFV600E colorectal cancer: a phase 2 trial J Tian, JH Chen, SX Chao, K Pelka, M Giannakis, J Hess, K Burke, ... Nature medicine 29 (2), 458-466, 2023 | 59 | 2023 |
Evan EichlerProfessor of Genome Sciences, University of Washington在 gs.washington.edu 的电子邮件经过验证
